β-Lactamase diversity in Acinetobacter baumannii

Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0078424. doi: 10.1128/aac.00784-24. Epub 2025 Feb 10.

Abstract

Acinetobacter baumannii is a clinically important, Gram-negative pathogen responsible for a wide variety of nosocomial and community-acquired infections. Antibiotic resistance is a serious concern, as the organism has a wide variety of intrinsic resistance mechanisms, including chromosomal class C (blaADC) and D (blaOXA-51 family) β-lactamases, and the ability to readily acquire additional β-lactamases. Surveillance studies can reveal the diversity and distribution of β-lactamase alleles, but are difficult and expensive to conduct. Herein, we describe an approach using publicly available data derived from whole genome sequences, to explore the diversity and distribution of β-lactamase alleles across 28,330 isolates. The most common intrinsic alleles at the time of writing were blaADC-73, blaADC-30, blaADC-222, blaADC-33, and blaOXA-66, and the most common acquired allele was blaOXA-23. Interestingly, only 63.0% of assigned blaADC alleles were encountered and the 10 most common blaADC and intrinsic blaOXA alleles represented approximately 75% of their respective gene totals while dozens were extremely infrequent. Differences were observed over time and geography. Surprisingly, more distinct unassigned (i.e., lacking a blaADC or blaOXA number) alleles were encountered than distinct, assigned alleles. Understanding the diversity and distribution of β-lactamase alleles helps to prioritize variants for further research, selects targets for drug development, and may aid in selecting therapies for a given infection.

Keywords: Acinetobacter baumannii; antibiotic resistance; beta-lactamases; bioinformatics.

MeSH terms

  • Acinetobacter Infections / drug therapy
  • Acinetobacter Infections / microbiology
  • Acinetobacter baumannii* / drug effects
  • Acinetobacter baumannii* / enzymology
  • Acinetobacter baumannii* / genetics
  • Alleles
  • Anti-Bacterial Agents / pharmacology
  • Drug Resistance, Multiple, Bacterial / genetics
  • Genetic Variation
  • Humans
  • Microbial Sensitivity Tests
  • Whole Genome Sequencing
  • beta-Lactamases* / genetics
  • beta-Lactamases* / metabolism

Substances

  • beta-Lactamases
  • Anti-Bacterial Agents